Journal Mobile Options
Table of Contents
Vol. 92, No. 2, 2007
Issue release date: August 2007
Neonatology 2007;92:91–95

Zinc Protoporphyrin/Heme in Large-for-Gestation Newborns

Kleven K.J. · Blohowiak S.E. · Kling P.J.
Department of Pediatrics, University of Wisconsin, Madison, Wisc., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Zinc protoporphyrin/heme (ZnPP/H) ratios are indicators of incomplete erythrocyte iron delivery. ZnPP/H is more sensitive than measures of iron stores, such as plasma ferritin, in identifying early pre-anemic iron-deficient erythropoiesis. Cord ZnPP/H ratios are elevated in conditions associated with fetal hypoxia, such as diabetes mellitus during pregnancy. In chronic fetal hypoxemia, erythrocyte and hemoglobin syntheses are accelerated and iron is incorporated into erythrocytes. Cord ZnPP/H ratios are correlated with fetal size after diabetic pregnancy. Because fetal size is a surrogate for diabetes control, it is unclear whether glycemic control in diabetes mellitus or fetal size was the major determinant of ZnPP/H ratios and disturbed erythrocyte iron delivery. Objective: Our goal was to examine whether ZnPP/H ratios were elevated or were associated with growth in large-for-gestation newborns born to mothers without the diagnosis of diabetes mellitus. Methods: In cord blood samples from large and appropriately grown healthy newborns, we measured ZnPP/H and indices of erythropoiesis and iron status. Analyses included simple linear regression, Fisher’s exact, and unpaired t testing. Results: In the absence of diabetes mellitus, ZnPP/H in 25 large and 24 appropriately grown healthy newborns was similar, and the ratios were within the limits of previously reported normal cord ZnPP/H. Ratios were not correlated with plasma ferritin levels. In large newborns, but not appropriately grown newborns, ZnPP/H ratios were positively correlated with fetal growth (p < 0.03) and estimates of body hemoglobin (p <0.04). Conclusions: Despite 33% greater body hemoglobin mass observed in healthy large, compared to appropriately grown newborns, mean ZnPP/H was normal. Iron incorporation into erythrocytes in large newborns appears adequate. Because the association of ZnPP/H with size and estimated body hemoglobin was observed only in large newborns, factors determining ZnPP/H may differ between large and appropriately grown newborns.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Georgieff MK, Landon MB, Mills MM, Hedlund BE, Faassen AE, Schmidt RL, et al: Abnormal iron distribution in infants of diabetic mothers: Spectrum and maternal antecedents. J Pediatr 1990;117:455–461.
  2. Siddappa AM, Georgieff MK, Wewerka SW, Worwa C, Nelson CA, deRegnier R-A: Iron deficiency alters auditory recognition memory in newborn infants of diabetic mothers. Pediatr Res 2004;55:1034–1041.
  3. Labbé RF, Dewanji A: Iron assessment tests: transferrin receptor vis-à-vis zinc protoporphyrin. Clin Biochem 2004;37:165–174.
  4. Rettmer RL, Carlson TH, Origenes ML, Jack RM, Labbé RF: Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency. Pediatrics 1999;104:e37.
  5. Miller SM, McPherson RJ, Juul SE: Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants. J Pediatr 2006;148:8–10.

    External Resources

  6. Juul SE, Zerzan JC, Strandjord TP, Woodrum DE: Zinc protoporphyrin/heme as an indicator of iron status in NICU patients. J Pediatr 2003;142:273–278.
  7. Winzerling JJ, Kling PJ: Iron deficient erythropoiesis in premature infants measured by blood zinc protoporphyrin/heme. J Pediatr 2001;139:134–136.
  8. Lott DG, Zimmerman MB, Labbé RF, Kling PJ, Widness JA: Erythrocyte zinc protoporphyrin ratios are elevated with prematurity and with fetal hypoxia. Pediatrics 2005;116:414–422.

    External Resources

  9. Lesser K, Schoel S, Widness JA, Kling PJ: Zinc protoporphyrin/heme ratios in infants born to women with diabetes. Am J Obstet Gynecol 2003;189:S106.

    External Resources

  10. Arbuckle TE, Wilkins R, Sherman GJ: Birth weight percentiles by gestational age in Canada. Obstet Gynecol 1993;81:39–48.
  11. American Diabetes Association: Gestational diabetes mellitus. Diabetes Care 2001;24:S77–S79.
  12. Widness JA, Clemons GK, Garcia JF, Oh W, Schwartz R: Increased immunoreactive erythropoietin in cord serum after labor. Am J Obstet Gynecol 1984;148:194–197.
  13. Hastka J, Lasserre JJ, Schwarzbeck A, Strauch M, Hehlmann R: Washing erythrocytes to remove interferents in measurements of zinc protoporphyrin is elevated by front-face hematofluorometry. Clin Chem 1992;38:2184–2189.
  14. Chockalingam UM, Murphy E, Ophoven JC, Weisdorf SA, Georgieff MK: Cord transferrin and ferritin values in newborn infants at risk for prenatal uteroplacental insufficiency and chronic hypoxia. J Pediatr 1987;111:283–286.
  15. Georgieff MK, Wobken JK, WElle J, Brudo JR, Connor JR: Identification and localization of divalent metal transporter-1 (DMT-1) in term human placenta. Placenta 2000;21:799–804.
  16. Halvorsen S, Bechensteen AG: Physiology of erythropoietin during mammalian development. Acta Paediatr 2002;438(suppl):17–26.

    External Resources

  17. Thorsdottir I, Gunnarsson BS, Atladottir H, Michaelsen KF, Palsson G: Iron status at 12 months of age – effects of body size, growth and diet in a population with high birth weight. Eur J Clin Nutr 2003;57:505–513.
  18. Michaelsen KF, Milman N, Samuelson G: A longitudinal study of iron status in healthy Danish infants: effects of early iron status, growth velocity and dietary factors. Acta Paediatr 1995;84:1035–1044.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50